IVVD - NASDAQ

Invivyd, Inc.

IVVD·NASDAQ

$1.14

+1.5%

HealthcareBiotechnology

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$151.31M

EPS-0.3000

P/E Ratio-8.10

Earnings Date08/13/2026

ivvd

Other Current Liabilities

Last Annual Value

19.11M

3-Year CAGR

47%

5-Year CAGR

89%

10-Year CAGR

37%

Adjust for Inflation

Invivyd, Inc. Competitors Analysis of Other Current Liabilities

IVVD · NASDAQ

Company	Other Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Invivyd, Inc. NASDAQ:IVVD	19.11M	21.0%	31.0%	N/A
OmniAb, Inc. NASDAQ:OABI	7.33M	-2.0%	8.3%	N/A
SELLAS Life Sciences Group, Inc. NASDAQ:SLS	3.52M	31.9%	16.4%	5.8%
Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP	16.84M	655.9%	163.1%	35.8%
Pyxis Oncology, Inc. NASDAQ:PYXS	8.55M	15.3%	21.5%	N/A
Cassava Sciences, Inc. NASDAQ:SAVA	43.83M	134.0%	133.5%	109.4%
Vor Biopharma Inc. NASDAQ:VOR	15.33M	45.6%	104.0%	N/A
Sangamo Therapeutics, Inc. NASDAQ:SGMO	25.43M	29.4%	4.1%	22.3%
Neonc Technologies Holdings, Inc. NASDAQ:NTHI	255.10K	-38.4%	-11.2%	N/A
C4 Therapeutics, Inc. NASDAQ:CCCC	13.31M	12.4%	19.4%	N/A
Insight Molecular Diagnostics Inc. NASDAQ:IMDX	7.72M	24.4%	2.9%	66.9%

Invivyd, Inc. Fair Value Envelope

IVVD · NASDAQ

Our analysis suggests that IVVD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.14, this represents a potential HIDDEN relative to our calculated worth for Invivyd, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.14

Related Guides

Blog Categories

Continue your IVVD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.